Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03434678 · ClinicalTrials.gov registry record · Phase 3
Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection
A Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 133
- Enrollment target
NCT03434678: Completed Phase 3 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03434678 is a Phase 3 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 133 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03434678, a Phase 3 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 133 participants
- Enrollment target
Study Summary
The purpose of this study is to see if there is a difference in complications in patients who have an epidural started earlier (during their surgery) and used as part of the anesthetic in addition to using it for post operative pain compared with patients who receive an epidural later in the surgery to be used only for post operative pain.
Interventions
- DRUG Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent, Bupivacaine 0.125% + Fentanyl 5 mcg/ml
- DRUG Propofol+ Rocuronium+ Fentanyl + Inhalational
- PROCEDURE Open Pancreaticoduodenectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2018-01-30 |
| Est. Completion | 2024-07-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03434678
The ClinicalTrials.gov registry entry for NCT03434678 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent, Bupivacaine 0.125% + Fentanyl 5 mcg/ml is the first listed.
NCT03434678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03434678 about?
NCT03434678 is a clinical study titled "Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection". The purpose of this study is to see if there is a difference in complications in patients who have an epidural started earlier (during their surgery) and used as part of the anesthetic in addition to using it for post operative pain compared with patients who receive an epidural later in the surgery...
What is the current status of trial NCT03434678?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 133 participants. The study started on 2018-01-30. Estimated completion is 2024-07-10.
What interventions are being tested in trial NCT03434678?
The interventions under investigation include: Propofol+ Rocuronium+ Fentanyl 2 mcg/kg+ Inhalational Agent, Bupivacaine 0.125% + Fentanyl 5 mcg/ml (DRUG), Propofol+ Rocuronium+ Fentanyl + Inhalational (DRUG), Open Pancreaticoduodenectomy (PROCEDURE).
Who is sponsoring clinical trial NCT03434678?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.